Reduced overall DA levels and significantly lowered D2R expression were found in Sagheddu et al.'s chronic neuropathic pain rat model [30], which provides possible new neuroplasticity targets for the treatment of chronic pain-induced depression. This evidence concerns the gene DRD2 and depressive disorder.